ERBB2 and breast cancer: PTEN, mRNA levels were significantly lower in TNBC compared to the normal breast, luminal A, luminal B and HER2+ subtypes, although PTEN mutation frequency was similar (~6%) across all subtypes of breast cancer (Supplementary Fig. S1a; P < 0.0001).